FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Per Malmström

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
S Alkner; Pär-Ola Bendahl; Mårten Fernö; D Grabau; Per Malmström; Lisa Rydén
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.
Stefan Broselid; Benxu Cheng; Mårten Fernö; Linda Hartman; Karin Jirström; Heather L P Klug-De Santiago; Kristina Lövgren; Per Malmström; Björn Olde; Martin Sjöström; Mattias Belting; Pär-Ola Bendahl; L M Fredrik Leeb-Lundberg
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
Karolina Holm; Jillian Howlin; Kristina Lövgren; Per Malmström; Steina Aradottir; Pär-Ola Bendahl; Stephen Ethier; Mårten Fernö; Dorthe Grabau; Sofia Gruvberger-Saal; Cecilia Hegardt; Lisa Rydén; Lao H Saal; Olle Stål; Ake Borg; Markus Ringnér
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Per Malmström (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S Alkner; Pär-Ola Bendahl; Mårten Fernö; D Grabau; Per Malmström; Lisa Rydén
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(5):1244-52.
2013: Stefan Broselid; Benxu Cheng; Mårten Fernö; Linda Hartman; Karin Jirström; Heather L P Klug-De Santiago; Kristina Lövgren; Per Malmström; Björn Olde; Martin Sjöström; Mattias Belting; Pär-Ola Bendahl; L M Fredrik Leeb-Lundberg
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(7):1681-92.
2012: Karolina Holm; Jillian Howlin; Kristina Lövgren; Per Malmström; Steina Aradottir; Pär-Ola Bendahl; Stephen Ethier; Mårten Fernö; Dorthe Grabau; Sofia Gruvberger-Saal; Cecilia Hegardt; Lisa Rydén; Lao H Saal; Olle Stål; Ake Borg; Markus Ringnér
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
Molecular oncology 2012;6(5):494-506.
2012: Göran Jönsson; Niklas Loman; Kristina Lövgren; Linda Magnusson; Per Malmström; Heli Nevanlinna; Håkan Olsson; Camilla Persson; Markus Ringnér; Lao H Saal; Johan Staaf; Johan Vallon-Christersson; Rainer Fagerholm; Mårten Fernö; Dorthe Grabau; Sofia K Gruvberger-Saal; Cecilia Hegardt; Päivi Heikkilä; Karolina Holm; Oskar T Johannsson; Ellinor Johnsson; Bjarni A Agnarsson; Adalgeir Arason; Rosa B Barkardottir; Åke Borg
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
Cancer research 2012;72(16):4028-36.
2011: Sara Margolin; Nils-Olof Bengtsson; Lena Carlsson; Per Edlund; Mats Hellstrøm; Per Karlsson; Elisabet Lidbrink; Barbro Linderholm; Henrik Lindman; Per Malmström; Dagny Pettersson Skøld; Martin Søderberg; Kenneth Villman; Jonas Bergh
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer.
Acta oncologica (Stockholm, Sweden) 2011;50(1):35-41.
2010: Marie Klintman; Sidse Ørnbjerg Würtz; Ib Jarle Christensen; Pernille Braemer Hertel; Mårten Fernö; Martin Malmberg; Henning Mouridsen; Frederik Cold; Anne-Sofie Schrohl; John A Foekens; Per Malmström; Nils Brünner
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.
Breast cancer research and treatment 2010;121(2):365-71.
2009: Fredrika Killander; Harald Anderson; Stefan Rydén; Torgil Möller; L O Hafström; Per Malmström
Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - a randomized trial from the South Sweden Breast Cancer Group.
Breast (Edinburgh, Scotland) 2009;18(5):309-15.
2009: Marie Magnusson; Peter Höglund; Karin Johansson; Charlotta Jönsson; Fredrika Killander; Per Malmström; Anna Weddig; Elisabeth Kjellén
Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
European journal of cancer (Oxford, England : 1990) 2009;45(14):2488-95.
2008: Sara Brommesson; Göran Jönsson; Carina Strand; Dorthe Grabau; Per Malmström; Markus Ringnér; Mårten Fernö; Ingrid Hedenfalk
Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs.
BMC clinical pathology 2008;8():6.
2008: Emma Niméus-Malmström; Morten Krogh; Per Malmström; Carina Strand; Irma Fredriksson; Per Karlsson; Bo Nordenskjöld; Olle Stål; Görel Ostberg; Carsten Peterson; Mårten Fernö
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy.
Breast cancer research : BCR 2008;10(2):R34.
2008: Piiha-Lotta Jerevall; Sara Brommesson; Carina Strand; Sofia Gruvberger-Saal; Per Malmström; Bo Nordenskjöld; Sten Wingren; Peter Söderkvist; Mårten Fernö; Olle Stål
Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.
Breast cancer research and treatment 2008;107(2):225-34.
2007: Fredrika Killander; Harald Anderson; Stefan Rydén; Torgil R Möller; Knut Aspegren; Jeanette Ceberg; Christina Danewid; Per Malmström
Radiotherapy and tamoxifen after mastectomy in postmenopausal women -- 20 year follow-up of the South Sweden Breast Cancer Group randomised trial SSBCG II:I.
European journal of cancer (Oxford, England : 1990) 2007;43(14):2100-8.
2007: Sofia K Gruvberger-Saal; Pär-Ola Bendahl; Lao H Saal; Mervi Laakso; Cecilia Hegardt; Patrik Edén; Carsten Peterson; Per Malmström; Jorma Isola; Ake Borg; Mårten Fernö
Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):1987-94.
2006: Mervi Laakso; Minna Tanner; Jonas Nilsson; Tom Wiklund; Bjørn Erikstein; Pirkko Kellokumpu-Lehtinen; Per Malmström; Nils Wilking; Jonas Bergh; Jorma Isola
Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4185-91.
2006: Minna Tanner; Jorma Isola; Tom Wiklund; Bjørn Erikstein; Pirkko Kellokumpu-Lehtinen; Per Malmström; Nils Wilking; Jonas Nilsson; Jonas Bergh
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2428-36.
2006: Kenneth Villman; Johanna Sjöström; Reino Heikkilä; Ragnar Hultborn; Per Malmström; Nils-Olof Bengtsson; Martin Söderberg; Eero Saksela; Carl Blomqvist
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer.
Acta oncologica (Stockholm, Sweden) 2006;45(5):590-6.
2003: Per Malmström; L Holmberg; Harald Anderson; Jonas Mattsson; Per-Ebbe Jönsson; L Tennvall-Nittby; G Balldin; L Lovén; J H Svensson; Christian Ingvar; Torgil R Möller; Erik Holmberg; Arne Wallgren
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening.
European journal of cancer (Oxford, England : 1990) 2003;39(12):1690-7.
2003: Minna-Liisa Luoma; Liisa Hakamies-Blomqvist; Johanna Sjöström; Anna Pluzanska; S Ottoson; Henning Mouridsen; Nils-Olof Bengtsson; Jonas Bergh; Per Malmström; Vahur Valvere; L Tennvall; Carl Blomqvist
Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(10):1370-6.
2003: Asa Lilja; Gudmund Smith; Per Malmström; Leif G Salford; Ingrid Idvall; Vibeke Horstman
Psychological profile in patients with Stages I and II breast cancer: associations of psychological profile with tumor biological prognosticators.
Psychological reports 2003;92(3 Pt 2):1187-98.
2002: Olli Tynninen; Johanna Sjöström; Kristina von Boguslawski; Nils-Olof Bengtsson; R Heikkilä; Per Malmström; Bjørn Ostenstad; Erik Wist; Vahur Valvere; Eero Saksela; Timo Paavonen; Carl Blomqvist
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients.
British journal of cancer 2002;86(12):1905-8.
2002: Johanna Sjöström; Carl Blomqvist; Kristina von Boguslawski; Nils-Olof Bengtsson; Ingvil Mjaaland; Per Malmström; Björn Ostenstadt; Erik Wist; Vahur Valvere; Shinichi Takayama; John C Reed; Eero Saksela
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):811-6.
2002: Johanna Sjöström; Juhani Collan; Kristina von Boguslawski; Kaarle Franssila; Nils-Olof Bengtsson; Ingvil Mjaaland; Per Malmström; B Østenstad; Erik Wist; Vahur Valvere; Jonas Bergh; D Skiöld-Petterson; Eero Saksela; Carl Blomqvist
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(4):535-42.
2001: Per Malmström; Pär-Ola Bendahl; P Boiesen; Nils Brünner; Ingrid Idvall; Mårten Fernö
S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):2010-9.
2001: Sylvie Romain; Pär-Ola Bendahl; O Guirou; Per Malmström; Pierre-Marie Martin; Mårten Fernö
DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients.
International journal of cancer. Journal international du cancer 2001;95(1):56-61.
2000: Olle Stål; A Borg; Mårten Fernö; Ann-Christin Källström; Per Malmström; Bo Nordenskjöld
ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1545-50.
2000: Jonas Bergh; Tom Wiklund; Bjørn Erikstein; Elisabet Lidbrink; Henrik Lindman; Per Malmström; Pirkko Kellokumpu-Lehtinen; Nils-Olof Bengtsson; G Söderlund; Gun Anker; Erik Wist; S Ottosson; E Salminen; P Ljungman; Harald Holte; J Nilsson; Carl Blomqvist; Nils Wilking
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
Lancet 2000;356(9239):1384-91.
2000: Johanna Sjöström; Carl Blomqvist; Päivi Heikkilä; K V Boguslawski; A Räisänen-Sokolowski; Nils-Olof Bengtsson; Ingvil Mjaaland; Per Malmström; B Ostenstadt; Jonas Bergh; Erik Wist; Vahur Valvere; Eero Saksela
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3103-10.
2000: Liisa Hakamies-Blomqvist; Minna-Liisa Luoma; Johanna Sjöström; Anna Pluzanska; M Sjödin; Henning Mouridsen; Bjørn Ostenstad; Ingvil Mjaaland; S Ottosson-Lönn; Jonas Bergh; Per Malmström; Carl Blomqvist
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.
European journal of cancer (Oxford, England : 1990) 2000;36(11):1411-7.
2000: Karin Källén; Bo Geijer; Per Malmström; AM Andersson; Stig Holtås; Erik Ryding; Ingmar Rosén
Quantitative 201Tl SPET imaging in the follow-up of treatment for brain tumour: a sensitive tool for the early identification of response to chemotherapy?
Nuclear medicine communications 2000;21(3):259-67.
2000: Mårten Fernö; Olle Stål; Bo Baldetorp; Thomas Hatschek; Ann-Christin Källström; Per Malmström; Bo Nordenskjöld; S Rydën
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. South Sweden Breast Cancer Group, and South-East Sweden Breast Cancer Group.
Breast cancer research and treatment 2000;59(1):69-76.
1998: Birgitta Bülow; R Attewell; Lars Hagmar; Per Malmström; Carl-Henrik Nordström; Eva Marie Erfurth
Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence.
The Journal of clinical endocrinology and metabolism 1998;83(11):3897-904.
1998: Asa Lilja; Gudmund Smith; Per Malmström; Leif G Salford; Ingrid Idvall
Psychological profile related to malignant tumours of different histopathology.
Psycho-oncology 1998;7(5):376-86.
1998: U Jungnelius; Ulrik Ringborg; Steinar Aamdal; Jonas Mattsson; Ulrika Stierner; Christian Ingvar; Per Malmström; R Andersson; M Karlsson; K Willman; Erik Wist; G Bjelkengren; Ronny Westberg
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
European journal of cancer (Oxford, England : 1990) 1998;34(9):1368-74.
1998: Asa Lilja; Gudmund Smith; Per Malmström; Leif G Salford
Attitude towards aggression and creative functioning in patients with breast cancer.
Perceptual and motor skills 1998;87(1):291-303.
1998: Jonas Bergh; Tom Wiklund; Bjørn Erikstein; Tommy Fornander; Nils-Olof Bengtsson; Per Malmström; Pirkko Kellokumpu-Lehtinen; Gun Anker; H Bennmarker; Nils Wilking
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):403-11.
1997: M P Sjövall; Per Malmström
Induction chemotherapy with versus without hormonal synchronisation in locally advanced breast cancer.
Acta oncologica (Stockholm, Sweden) 1997;36(2):207-12.
1993: Lars-Göran Strömblad; H Anderson; Per Malmström; Leif G Salford
Reoperation for malignant astrocytomas: personal experience and a review of the literature.
British journal of neurosurgery 1993;7(6):623-33.
1991: M Sandberg-Wollheim; Per Malmström; Lars-Göran Strömblad; H Anderson; S Borgström; A Brun; S Cronqvist; K Hougaard; Leif G Salford
A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.
Cancer 1991;68(1):22-9.